Motens

Lacidipine · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Motens, covering 2014-09-10 to 2014-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension